|
|
| To enact section 4729.553 of the Revised Code to | 1 |
| require a retail terminal distributor of dangerous | 2 |
| drugs to verify the prospective purchaser's | 3 |
| identity when dispensing a controlled substance or | 4 |
| tramadol. | 5 |
| Section 1. That section 4729.553 of the Revised Code be | 6 |
| enacted to read as follows: | 7 |
| Sec. 4729.553. (A) As used in this section, "purchaser" means | 8 |
| an individual engaged in the act of purchasing a dangerous drug | 9 |
| from a licensed terminal distributor of dangerous drugs and | 10 |
| includes either the individual for whom the prescription for the | 11 |
| drug is issued or an individual acting on behalf of the individual | 12 |
| for whom the prescription is issued. | 13 |
| (B) Except as provided in division (E) of this section, prior | 14 |
| to selling at retail a controlled substance or drug containing | 15 |
| tramadol, a licensed terminal distributor of dangerous drugs shall | 16 |
| do both of the following: | 17 |
| (1) Verify the identity of the prospective purchaser of the | 18 |
| drug against either of the following: | 19 |
| (a) A valid identification card bearing a photograph of the | 20 |
| prospective purchaser, issued by a state or federal agency; | 21 |
| (b) A form of identification authorized by the state board of | 22 |
| pharmacy in rules adopted under division (D) of this section. | 23 |
| (2) Record all of the following: | 24 |
| (a) The name of the individual purchasing the drug; | 25 |
| (b) The type of identification presented; | 26 |
| (c) The unique identification number printed by the issuing | 27 |
| agency on the identification, if the number exists. | 28 |
| (C) The terminal distributor shall retain the information | 29 |
| required by division (B) of this section for three years. The | 30 |
| information is subject to inspection for official purposes by law | 31 |
| enforcement officers and employees of the board. | 32 |
| (D) The board may adopt rules authorizing for purposes of | 33 |
| this section the use of identification other than that described | 34 |
| in division (B)(1)(a) of this section. The rules shall be adopted | 35 |
| in accordance with Chapter 119. of the Revised Code. | 36 |
| (E) Division (B) of this section does not apply when a drug | 37 |
| is being purchased for use in administering the drug to an | 38 |
| individual who is receiving care in or through a hospital, | 39 |
| ambulatory surgical facility, nursing home, residential care | 40 |
| facility, freestanding rehabilitation facility, hospice care | 41 |
| program, home and community-based services provider, residential | 42 |
| facility for individuals with mental illness or developmental | 43 |
| disabilities, physician office, or any similar health care | 44 |
| facility, location, or provider. | 45 |